Cometriq Interactions
There are 531 drugs known to interact with Cometriq (cabozantinib), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 322 are major, 206 are moderate, and 3 are minor.
- View all 531 medications that may interact with Cometriq
- View Cometriq alcohol/food interactions (2)
- View Cometriq disease interactions (8)
Most frequently checked interactions
View interaction reports for Cometriq (cabozantinib) and the medicines listed below.
- acetaminophen / hydrocodone
- acetaminophen / oxycodone
- Advil (ibuprofen)
- Afinitor (everolimus)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- Allegra Allergy (fexofenadine)
- allopurinol
- amitriptyline
- Ampyra (dalfampridine)
- Anafranil (clomipramine)
- anastrozole
- Aptivus (tipranavir)
- Aranesp (darbepoetin alfa)
- Aredia (pamidronate)
- Arixtra (fondaparinux)
- atenolol
- Avastin (bevacizumab)
- Baraclude (entecavir)
- Benadryl (diphenhydramine)
- Benefiber Powder (wheat dextrin)
- Caprelsa (vandetanib)
- denosumab
- ibuprofen
- levothyroxine
- ondansetron
- Sandostatin LAR Depot (octreotide)
- sertraline
- zoledronic acid
Cometriq alcohol/food interactions
There are 2 alcohol/food interactions with Cometriq (cabozantinib).
Cometriq disease interactions
There are 8 disease interactions with Cometriq (cabozantinib) which include:
- hemorrhagic events
- GI perforation
- hepatic impairment
- hypertension
- renal impairment
- RPL syndrome
- thromboembolism
- lung toxicity
Report options
More about Cometriq (cabozantinib)
- Cometriq consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Armour Thyroid
Armour Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid ...
NP Thyroid
NP Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid cancer ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Lenvima
Lenvima (lenvatinib) is used to treat thyroid cancer, advanced renal cell carcinoma, hepatocellular ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Dabrafenib
Dabrafenib systemic is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer ...
Trametinib
Trametinib systemic is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer ...
Sorafenib
Sorafenib systemic is used for hepatic tumor, hepatocellular carcinoma, renal cell carcinoma ...
Lenvatinib
Lenvatinib is used to treat thyroid cancer, kidney cancer, liver cancer, and advanced endometrial ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.